5 hours ago
2
- Boston Scientific Corporation (NYSE:BSX) has received approval from the U.S. FDA to update the label for its Farapulse Pulsed Field Ablation System.
- The new labelling now allow the system to be used for treating persistent atrial fibrillation, a condition causes the
English (US) ·